[B069] 转化医学检索
通过药物、靶点、适应症、机构、主题、转化阶段、期刊、会议等字段,获取转化医学相关数据
以下查询条件必须存在一个或多个:drug、target、disease、organizations、mechanism、drugType、keywords、subject、translationStage、publicationDate、journal、conference。keywords 参数最多支持20个值。conference的值获取可以参考产品,会议与年份之间需要用空格隔开。
请求参数
此 API 接口支持的参数列表
| 名称 | 类型 | 示例 | 描述 |
|---|---|---|---|
| array | [
"WCLC 2025",
"AACR 2024",
"ADA 2025"
] | 会议名称,参考产品会议名称 |
| array | [
"f98fd32baa8447119bb87f84093b925c",
"74d974da49ba407195b38595a0aff704"
] | 适应症 |
| object | Please check the form: DrugFilterAndCondition | 药物,condition默认为OR,支持AND |
| string | OR | 条件,OR或AND |
| array | [
"c7a2671dc0574f19bc42d557eca3906f",
"9ae626b75273433f8f4203ee3f7aa181"
] | 值列表 |
| array | [
"6718bf09d6024f4db4f309a4cc791cf6",
"6be383aaee904d2b8321e2d1fdacf8bb"
] | 药物类型 |
| array | [
"N Engl J Med",
"Nat Med"
] | 期刊名称,Nature | Science | Cell | Lancet | N Engl J Med | Proc Natl Acad Sci U S A | Nat Commun | Nat Genet | Nat Med | Sci Transl Med | J Med Chem |
| object | Please check the form: KeywordsFilterAndCondition | 关键词 |
| string | OR | 条件,OR或AND |
| array | [
"Sacituzumab govitecan",
"Oral"
] | 值列表 |
| integer<int64> | 10 | 返回条数,默认10。 offset + limit <= 10000, limit最大设置100 |
| array | [
"cf1cf8ea0f9b80ee88876a3324ceac99",
"888b99dda6a62ef2551937c34e253e9c"
] | 作用机制 |
| integer<int64> | - | 偏移量,默认0 |
| array | [
"5c1eb05d43334b6d6d7973ee3073b7b4",
"52aee12631589b24dca3ae62de8a0886"
] | 机构 |
| object | Please check the form: PublicationDateFilter | 发布时间,1:1周内 | 2:1个月内 | 3:1年内 | 4:3年内 | 5:自定义 |
| string | 2024-12-31 | 结束时间(自定义时使用) |
| string | 2024-01-01 | 开始时间(自定义时使用) |
| integer<int32> | 4 | 时间范围类型,1:1周内 | 2:1个月内 | 3:1年内 | 4:3年内 | 5:自定义 |
| array | Please check the form: SortField | 字段排序,field支持: PUB_DT, order支持desc, asc (默认desc) |
| string | PUB_DT | 排序字段,支持: PUB_DT |
| string | desc | 排序顺序,desc或asc,默认desc |
| array | [
"3期临床研究"
] | 主题/标签,流行病学|致病机理|靶点|生物标志物|结构生物学|药物发现/临床前|1期临床研究|1/2期临床研究|2期临床研究|2/3期临床研究|3期临床研究|上市后研究|真实世界研究|新技术 |
| object | Please check the form: TargetFilterAndCondition | 靶点,condition默认为OR,支持AND |
| string | OR | 条件,OR或AND |
| array | [
"d8cdb9ce63174077a9ef868b39bf3421",
"c385dcba5fea4e97bf02bc256757613a"
] | 值列表 |
| array | [
"T2"
] | 转化阶段,T0 | T1 | T2 | T3 |
响应结构
API 响应数据的结构说明
| 字段名 | 类型 | 示例 | 描述 |
|---|---|---|---|
data | object | - | 响应数据 |
items | array | Please check the form:TranslationalMedicineSearchDataDetail | 查询结果 |
drugs | array | Please check the form: CommonDrug | 药物 |
drug_id | string | e82b83b42eba4e5ea3f26f8e06081a5a | 药物ID |
display_name | array | [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
},
{
"lang": "CN",
"name": "雷珠单抗"
}
] | 药物名称,引用“CommonName” |
lang | string | EN | 语言 |
name | string | Ranibizumab (Genentech) | 药物、靶点、机构、适应症、国家/地区、字典、作用机制 名称 |
title | string | Novel Biomarker Discovery in Cancer Research | 标题 |
disease | array | Please check the form: CommonDisease | 适应症 |
disease_id | string | 06a9082fe1ec4c97bea31d888b9cfdce | 适应症ID |
display_name | array | [
{
"lang": "EN",
"name": "Uveitic Macular Edema"
},
{
"lang": "CN",
"name": "葡萄膜炎黄斑水肿"
}
] | 适应症名称,引用“CommonName” |
journal | object | Please check the form: CommonNorIdName | 期刊 |
name | string | Acute Kidney Injury | 名称 |
normalized_id | string | 87bfaf037f8e60c9e25595cd98bb27e4 | 标准ID |
subject | array | Please check the form: CommonNorIdName | 主题 |
targets | array | Please check the form: CommonTarget | 靶点 |
target_id | string | 1c2067e5ab054a8995f73efcfcf56207 | 靶点ID |
short_name | array | [
{
"lang": "EN",
"name": "VEGF"
}
] | 靶点简称,引用“CommonName” |
display_name | array | [
{
"lang": "EN",
"name": "Vascular endothelial growth factor"
},
{
"lang": "CN",
"name": "血管内皮生长因子"
}
] | 靶点全称,引用“CommonName” |
drug_type | array | Please check the form: CommonDictionary | 药物类型 |
display_name | array | [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
] | 字典名称 |
normalized_id | string | 2fbfdb3e92d942c48cbb0adb79f23526 | 字典ID |
technology | array | Please check the form: CommonNorIdName | 技术 |
source_info | array | Please check the form: TranslationalMedicineSourceInfo | 来源信息 |
code | string | NATURE-2024-001 | 编码 |
source | string | Nature | 来源 |
patsnap_id | string | patsnap_1234567890 | PatSnap ID |
source_url | string | https://www.nature.com/articles/s41586-024-01234-5 | 来源URL |
normalized_source_id | string | 368cf867-f484-430e-9530-44f5cccdd973 | 标准化来源ID |
normalized_source_category | string | Journal | 标准化来源类别 |
organization | array | Please check the form: CommonOrganization | 机构 |
display_name | array | [
{
"lang": "EN",
"name": "Roche Holding AG"
},
{
"lang": "CN",
"name": "罗氏"
}
] | 机构名称,引用“CommonName” |
organization_id | string | 87bfaf037f8e60c9e25595cd98bb27e4 | 机构ID |
mechanism_action | array | Please check the form: CommonMechanismAction | 作用机制 |
short_name | array | [
{
"lang": "EN",
"name": "KRAS G12C inhibitors"
},
{
"lang": "CN",
"name": "KRAS G12C抑制剂"
}
] | 作用机制简称 |
display_name | array | [
{
"lang": "EN",
"name": "GTPase KRas G12C inhibitors"
},
{
"lang": "CN",
"name": "KRAS G12C突变抑制剂"
}
] | 作用机制 名称 |
mechanism_id | string | 27c0848a265e4332836e10d0e8202b4c | 作用机制ID |
publication_date | string | 2024-01-15 | 出版日期 |
translation_stage | array | Please check the form: CommonNorIdName | 转化阶段 |
translational_medicine_id | string | tm_1234567890abcdef | 转化医学ID |
limit | integer<int64> | 10 | 返回条数 |
total | integer<int64> | 10 | 总量 |
offset | integer<int64> | - | 偏移量 |
status必填 | boolean | false | 状态 |
error_msg | string | The request parameter format is incorrect! | 错误信息 |
error_code必填 | integer | 0 | 错误代码 |
成功响应示例
成功调用 API 的响应示例
JSON
{
"data": {
"items": [
{
"drugs": [
{
"drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
],
"title": "Novel Biomarker Discovery in Cancer Research",
"disease": [
{
"disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
],
"journal": {
"name": "Acute Kidney Injury",
"normalized_id": "87bfaf037f8e60c9e25595cd98bb27e4"
},
"subject": [
{
"name": "Acute Kidney Injury",
"normalized_id": "87bfaf037f8e60c9e25595cd98bb27e4"
}
],
"targets": [
{
"target_id": "1c2067e5ab054a8995f73efcfcf56207",
"short_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
],
"drug_type": [
{
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
}
],
"technology": [
{
"name": "Acute Kidney Injury",
"normalized_id": "87bfaf037f8e60c9e25595cd98bb27e4"
}
],
"source_info": [
{
"code": "NATURE-2024-001",
"source": "Nature",
"patsnap_id": "patsnap_1234567890",
"source_url": "https://www.nature.com/articles/s41586-024-01234-5",
"normalized_source_id": "368cf867-f484-430e-9530-44f5cccdd973",
"normalized_source_category": "Journal"
}
],
"organization": [
{
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
}
],
"mechanism_action": [
{
"short_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"mechanism_id": "27c0848a265e4332836e10d0e8202b4c"
}
],
"publication_date": "2024-01-15",
"translation_stage": [
{
"name": "Acute Kidney Injury",
"normalized_id": "87bfaf037f8e60c9e25595cd98bb27e4"
}
],
"translational_medicine_id": "tm_1234567890abcdef"
}
],
"limit": 10,
"total": 10,
"offset": 0
},
"status": true,
"error_code": 0
}错误码
此接口可能返回的错误码列表
业务错误码
| 错误码 | 描述 |
|---|---|
68300004 | 请求参数异常! |
68300005 | 查询Api失败! |
68300006 | 解析基本存取错误! |
68300007 | 存在错误的请求! |
68300008 | 服务中断异常,请稍后再试! |
68300010 | 文件不符合上传规范! |
平台错误码
| 错误码 | 描述 |
|---|---|
67200000 | API整体限流错误! |
67200001 | API整体限流错误! |
67200002 | 当前调用速率过快,超过当前配置限制QPS! |
67200003 | 申请token的key和secret传参不正确或者客户端已被禁用! |
67200004 | 请求的接口无权限请联系我们的支持人员! |
67200005 | 账户余额/调用次数不足! |
67200006 | 客户端超过开通有效期! |
67200007 | 当前调用超过当天配置使用额度! |
67200008 | 请检查query参数中必填的apikey是否传输! |
67200009 | apikey与所传的bearerToken不匹配,请检查是否使用在有效期内的token! |
67200012 | 请求不合法! |
67200100 | 当前服务器状态正忙,请求响应超时! |
67200101 | 当前请求的Api不存在请检查请求Path! |
HTTP 状态码
| 状态码 | 描述 |
|---|---|
0 | 请求成功 |
201 | Created |
401 | Unauthorized |
403 | Forbidden |
404 | Not Found |
性能指标
此接口的预期性能特征
正常响应时间
5000 ms
最大响应时间
10000 ms